Perry Premdas

Perry Premdas

Director/Board Member chez OPX Biotechnologies, Inc.

Fortune : 8 M $ au 31/03/2024

71 ans
Process Industries
Health Technology
Consumer Services

Profil

Perry W.
Premdas
is currently a Director at OPX Biotechnologies, Inc. He previously served as an Independent Director at Balchem Corp.
from 2008 to 2023, and as a Director at Fresenius Kabi Pharmaceuticals Holding LLC from 2008 to 2011.
Mr. Premdas also held various Director positions at Ferro Corp., J.
M.
Huber Corp., and HNA Holdings, Inc. Additionally, he served as the Chief Financial Officer at Celanese AG from 1999 to 2004 and at Centeon LLC from 1997 to 1998.
Mr. Premdas received his undergraduate degree from Brown University and his MBA from Harvard Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
24/04/2023 51 008 ( 0,16% ) 8 M $ 31/03/2024

Postes actifs de Perry Premdas

SociétésPosteDébut
Director/Board Member 01/01/2012
Tous les postes actifs de Perry Premdas

Anciens postes connus de Perry Premdas

SociétésPosteFin
BALCHEM CORPORATION Director/Board Member 22/06/2023
COMPASS MINERALS INTERNATIONAL, INC. Director/Board Member 01/05/2015
Director/Board Member 17/02/2011
Director of Finance/CFO 01/01/2004
Centeon LLC Director of Finance/CFO 01/01/1998
Voir l'expérience en détail de Perry Premdas

Formation de Perry Premdas

Brown University Undergraduate Degree
Harvard Business School Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Perry Premdas

Relations

100 +

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
BALCHEM CORPORATION

Consumer Non-Durables

COMPASS MINERALS INTERNATIONAL, INC.

Process Industries

Entreprise privées7

Process Industries

Process Industries

Process Industries

Process Industries

Health Technology

Health Technology

Centeon LLC

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Perry Premdas